Follow the Natco Pharma Limited stock price and the full insider trade history of the company, a publicly traded company based in India. Shares are quoted on IN IN, under the authority of SEBI (PIT + SAST). Operating in the Health Care sector, Natco Pharma Limited has logged 76 insider filings. Market capitalisation: €159.2bn. The latest transaction was filed on 11 March 2026 (Sale). Among the most active insiders: SATYA VANI NANNAPANENI. All data is openly available.
76
Insider Decl.
0
Thresholds
€572,962
28 ops.
Buy Volume
€7m
48 ops.
Sell Volume
10Σ signal
Buys €572,962€7m Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 1,212 of 25,619 companies
79.4
score / 100
Value
71
Quality
88
FCF yld7.8%
Earn yld8.1%
EV/EBITDA10.5x
ROE17%
Gross mgn83%
Net mgn35%
Debt/EBITDA0.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.